These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 16518761)
1. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Wiese L; Hempel C; Penkowa M; Kirkby N; Kurtzhals JA Malar J; 2008 Jan; 7():3. PubMed ID: 18179698 [TBL] [Abstract][Full Text] [Related]
3. On recombinant human erythropoietin preventing the death of mice during cerebral malaria. Lackner P; Helbok R; Schmutzhard E J Infect Dis; 2007 May; 195(9):1391; author reply 1391-2. PubMed ID: 17397015 [No Abstract] [Full Text] [Related]
4. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice. Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290 [TBL] [Abstract][Full Text] [Related]
5. Artesunate-erythropoietin combination for murine cerebral malaria treatment. Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468 [TBL] [Abstract][Full Text] [Related]
14. Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly. Kaur A; Kinhikar AG; Singh PP Acta Trop; 2004 Jun; 91(1):27-41. PubMed ID: 15158686 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352 [TBL] [Abstract][Full Text] [Related]
16. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Chang KH; Stevenson MM Int J Parasitol; 2004 Dec; 34(13-14):1501-16. PubMed ID: 15582527 [TBL] [Abstract][Full Text] [Related]
17. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]